DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)

South Korea · Delayed Price · Currency is KRW

8,720.00

-686.07 (-7.29%)

At close: Jun 26, 2026

-40.88% (1Y)

Market Cap	172.19B -39.2%
Revenue (ttm)	143.42B -5.3%
Net Income	1.82B +3.8%
EPS	102.87 +4.0%
Shares Out	17.52M
PE Ratio	95.55
Forward PE	n/a
Dividend	150.00 (1.71%)
Ex-Dividend Date	Jun 29, 2026

Volume	72,007
Open	9,410.00
Previous Close	9,406.07
Day's Range	8,690.00 - 9,450.00
52-Week Range	8,690.00 - 24,900.00
Beta	-0.16
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About DAE HWA Pharmaceutical

DAE HWA Pharmaceutical Co., Ltd., a pharmaceutical company, produces and supplies pharmaceutical products in South Korea. The company offers drugs for anticancer, antibiotics, antifungal and skin ailment, antivirus, anti-allergosis, hemorrhoids, antidepressant, antiepileptic, psychotropic agent, anti respiratory, anti-inflammatory, analgesic, skeletal muscle relaxants, osteoporosis, anti-arthritis, gastro-intestinal, obesity, antispasmodic, diabetics, hypertension, hyperlipemia, antithrombotic and anticoagulant, hepatic, erectile dysfunction, u... [Read more]

Industry Pharmaceutical Preparations

Founded 1984

Employees 308

Stock Exchange KOSDAQ

Ticker Symbol 067080

Full Company Profile

Financial Performance

In 2025, DAE HWA Pharmaceutical's revenue was 143.06 billion, a decrease of -4.25% compared to the previous year's 149.41 billion. Earnings were 1.65 billion, an increase of 211.15%.

Financial Statements